K
LIVE

Serial Number

79185467

Owner

KYOWA HAKKO KIRIN CO., LTD.

Filing Date

Dec 10, 2015

Add to watchlist:

No watchlists yet
View on USPTO

K Trademark

Serial Number: 79185467 • Registration: 5202159

K is a trademark filed by KYOWA HAKKO KIRIN CO., LTD. on December 10, 2015. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

KYOWA HAKKO KIRIN CO., LTD. (58 trademarks)

1-6-1, OHTEMACHI, CHIYODA-KU
TOKYO , JP

Entity Type: 99

Trademark Details

Filing Date

December 10, 2015

Registration Date

May 16, 2017

Published for Opposition

February 28, 2017

Cancellation Date

December 1, 2023

Goods & Services

Custom manufacture of pharmaceuticals; extraction, production and synthesis of pharmaceuticals for others; custom manufacture of industrial chemicals; custom manufacture of medical apparatus and medical instruments; manufacture of antibody-producing cells for others

Pharmaceuticals, namely, diagnostic preparations for medical purposes, chemical reagents for medical or veterinary purposes, diagnostic reagents for medical use and vitamin preparations, pharmaceuticals for the treatment of cancer and malignant tumors, pain, hematological disorders, renal diseases, endocrine diseases, immunity disorders, neurological, psychiatric and other central nervous system disorders, infectious diseases, parasitic diseases, nutritional diseases, metabolic diseases, congenital malformations, traumatic injury, eye diseases, ear diseases, circulatory system diseases, diseases of the respiratory system, digestive system diseases, skin diseases, diseases of the musculoskeletal system and diseases of the genitourinary system; pharmaceutical preparations, namely, diagnostic preparations for medical purposes, chemical reagents for medical or veterinary purposes, diagnostic reagents for medical use and vitamin preparations, pharmaceutical preparations for the treatment of cancer and malignant tumors, pain, hematological disorders, renal diseases, endocrine diseases, immunity disorders, neurological, psychiatric and other central nervous system disorders, infectious diseases, parasitic diseases, nutritional diseases, metabolic diseases, congenital malformations, traumatic injury, eye diseases, ear diseases, circulatory system diseases, diseases of the respiratory system, digestive system diseases, skin diseases, diseases of the musculoskeletal system and diseases of the genitourinary system; cells for medical purposes; bacteriological culture mediums for medical and veterinary purposes for use in augmentation, differentiation and cultivation of bone, tissue and cells; cell culture mediums for medical and veterinary purposes for use in augmentation, differentiation or cultivation of bone, tissue and cells; cell culture mediums for research and for scientific purposes and for medical or veterinary purposes for use in augmentation, differentiation or cultivation of bone, tissue and cells; reagent paper for medical purposes; gauze for dressings; empty capsules for pharmaceuticals; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; lacteal flour for babies; dietary supplements; dietetic beverages, namely, juice drinks, jelly drinks and milk adapted for medical purposes; dietetic foods, namely, crackers, candy, jelly adapted for medical purposes; beverages for babies adapted for medical purposes; food for babies; dietary supplements for animals

Industrial chemicals; chemicals for use in the manufacture of dietary supplements and foods; chemical additives for use in the manufacture of dietary supplements and foods; amino acids for use in the manufacture of dietary supplements and foods; bacteriological culture mediums other than for medical or veterinary purposes; cell culture mediums other than for medical or veterinary purposes; cell culture mediums for research and for scientific purposes, other than for medical or veterinary purposes; plant growth regulating preparations; artificial sweeteners

Apparatus for use in medical analysis, namely, apparatus for analysis of biological materials for medical purposes, apparatus for analysis of chemicals for medical purposes, apparatus for analysis of drugs, apparatus for analysis of drug metabolites, medical diagnostic instruments for the analysis of body fluids; medical apparatus, namely, injection device for pharmaceuticals, injection needles for medical purposes, inhalation device for pharmaceuticals, defibrillators, medical apparatus for treating respiratory conditions, infusion devise for administering drugs, infusion pumps for delivering measured amounts of solutions into the bloodstream over time, blood transfusion apparatus, blood component separation apparatus for medical purposes, diagnostic apparatus for detecting cancer, diagnostic apparatus for detecting infection, diagnostic apparatus for detecting the disease state of human illnesses, containers and trays specially designed for transporting and holding pharmaceuticals, high frequency electromagnetic therapy apparatus, low frequency electric therapy apparatus, short wave therapy machines and apparatus, static electric therapy apparatus, ultraviolet radiator units for therapeutic purposes, infrared radiator units for therapeutic purposes, mercury arc lamp units for therapeutic purposes, carbon arc lamp units for therapeutic purposes, massage apparatus for medical purposes; medical instruments, namely, for use in injection for administering drugs, infusion for administering drugs, inhalation for administering drugs, transfusion, separation of blood component for medical purposes, diagnosis for detecting cancer, diagnosis for detecting infection, diagnosis for detecting the disease state of human illnesses, transporting and holding pharmaceuticals, analysis of biological materials for medical purposes, analysis of chemicals for medical purposes, analysis of drugs, analysis of drug metabolites, analysis of body fluids; surgical apparatus, namely, for use in open heart surgery for monitoring oxygen gas analysis and vital sign, open abdominal surgery for monitoring oxygen gas analysis and vital sign, open chest surgery for monitoring oxygen gas analysis and vital sign; surgical instruments, namely, for use in open heart surgery for monitoring oxygen gas analysis and vital sign, open abdominal surgery for monitoring oxygen gas analysis and vital sign, open chest surgery for monitoring oxygen gas analysis and vital sign; gloves for medical purposes

Pharmaceutical research; research of chemicals; analysis of chemicals; testing, inspection or research of pharmaceuticals; testing, inspection or research of chemicals; testing, inspection or research of cosmetics; testing, inspection or research of foodstuff; providing technical advice relating to chemical research; providing technical advice relating to pharmaceutical development; providing technical advice relating to chemical development; rental of laboratory apparatus; rental of laboratory instruments

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Aug 24, 2024 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Aug 8, 2024 INTS
INVALIDATION PROCESSED
Aug 8, 2024 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 2, 2024 INTR
CANCELLED SECTION 71
Dec 1, 2023 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 16, 2022 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 20, 2017 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 22, 2017 FICS
FINAL DISPOSITION PROCESSED
Aug 22, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 16, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
May 16, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 28, 2017 NPUB
PUBLISHED FOR OPPOSITION
Feb 28, 2017 PUBO
NOTIFICATION PROCESSED BY IB
Feb 24, 2017 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 8, 2017 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 8, 2017 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 8, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 26, 2017 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 7, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 19, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 18, 2016 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 18, 2016 ERFR
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Oct 27, 2016 RDX3
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Oct 27, 2016 RDX1
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Oct 27, 2016 RRDX
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 5, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 5, 2016 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 5, 2016 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 3, 2016 GNFN
FINAL REFUSAL E-MAILED
Sep 3, 2016 GNFR
FINAL REFUSAL WRITTEN
Sep 3, 2016 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 12, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 12, 2016 CRFA
ASSIGNED TO LIE
Aug 12, 2016 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 3, 2016 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 3, 2016 TCCA
REFUSAL PROCESSED BY IB
May 14, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 11, 2016 RFCS
REFUSAL PROCESSED BY MPU
Apr 11, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 8, 2016 RFCR
NON-FINAL ACTION WRITTEN
Apr 7, 2016 CNRT
APPLICATION FILING RECEIPT MAILED
Apr 5, 2016 MAFR
ASSIGNED TO EXAMINER
Apr 1, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 1, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 31, 2016 REPR